Warberg Asset Management LLC
Position in CLDI — Calidi Biotherapeutics, Inc.
CIK 1597506
WINNETKA, IL
Position in CLDI
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$59,750
+$31,319 QoQ
Shares Held
15,625
+1236.6% QoQ
Ownership
0.605%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Warberg Asset Management LLC holds $403,990 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,000 | $301,030 | |
| 2 | RNTX |
Rein Therapeutics, Inc.
|
99,000 | $102,960 | |
| 3 | BIVI |
Biovie Inc.
|
613,426 | $0 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
94,797 | $0 | |
| 5 | BCTX |
BriaCell Therapeutics Corp.
|
159,555 | $0 | |
| 6 | ERNA |
Ernexa Therapeutics Inc.
|
69,430 | $0 |
All Filings in CLDI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,750 | 250,000 | Shares | Sole | 2026-05-07 | |
| 2025-09-30 | $28,431 | 18,705 | Shares | Sole | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||